Trailer
Robert Kenner Interview
* Junk Food Inc.
Robert E. Willner - Deadly Deception (1994)
Live at Hollywood Roosevelt Hotel, Greensboro (US)
BBC - Guinea Pig Kids, Edited Version (2004) - Subtitulado
NBC - U.S. medical tests during the 1940's
* Excerpt from "Deadly Deception" / White Paper on the Viral-AIDS Hypothesis
Robin Scovill - The Other Side of AIDS (2004)
About:
2003-2004,
AIDS,
Robin Scovill,
Versiones Subtituladas
Subtitulado
Questioning AIDS in South Africa (2000)
Baxter - Business & People (2009)
About:
Baxter,
Big Pharma
About
- 1980's: Contaminated hemophilia blood products infected HIV and Hepatitis C worldwide.
- 2001: Malfunctioning dialysis machines resulted in several deaths in Spain.
- 2008: Intentional contaminated heparin processed in China from pig's intestines by Scientific Protein Laboratories (Arsenal Capital Partners) resulted in several deaths and serious injuries. Due to procedural errors Changzhou facilities was never subject to an inspection by FDA official, as required by FDA rules. Factory's products also never certified as safe for use in pharmaceutical products by Chinese FDA officials as Changzhou Scientific Protein Laboratories was itself registered as a chemical company and not a drugs manufacturer.
- 2009: Contaminated vaccine material with Avian flu virus sent to a series of European laboratories. Joseph Moshe, dual national (Israeli-American) Mossad biowar expert, attacked and seized by Federal Agents and LAPD in California, after speaking to Dr. True Ott on his national radio show and warning of a plot by Baxter International to spread a Plague from Baxter's Ukrainian lab.
- Net income: $2.2 billion in 2008 ; $1.8 billion in 2007.
- Worldwide sales: $12.3 billion in 2008; $11.3 billion in 2007; $9.8 billion in 2005; $9.5 billion in 2004; $8.9 billion in 2003.
Novartis - Business
About:
Big Pharma,
Novartis
About
- Novartis = Merger of Ciba-Geigy Ltd. and Sandoz Laboratories in 1996.
- Ciba-Geigy = Merger of J. R. Geigy Ltd. and Ciba in 1970.
- Revenues: $53 billion in 2008.
- Net sales: $41.5 billion in 2008; $39.8 billion in 2007; $37 billion in 2006.
- Net income: $8.2 billion in 2008; $12.0 billion in 2007; $7.2 billion in 2006.
- Full member of the European Federation of Pharmaceutical Industries and Associations.
GlaxoSmithKline - Wellcome Trust
About:
Big Pharma,
Eugenics,
GSK
About
Henry Solomon Wellcome
- Freemason.
- Creates holding company, The Wellcome Foundation Limited (1924).
- Knight Commander of the British Empire and Honorary Fellow of the Royal College of Surgeons of England (1932).
- Collection of around 1.5 million books and objects relating to history and medicine; Artefacts specific to medicine and healing, including large quantities of weapons, bales of fabric, furniture, ancient cooking implements, porcelain, glassware, statues, coins, medals, objets d'art and even torture instruments; Sample of the hair of various historical figures, including George Washington, George III, Napoleon Bonaparte and the Duke of Wellington.
- Funded excavations at Jebel Moya, south of Khartoum, Sudan, hiring 4000 people to excavate (1911-1914).
- Abiding interest in Native American culture, through financial support and political lobbying helped establish a model Christian community amongst the Tsimshean people in British Columbia and establish an alternative site in Alaska.
GlaxoSmithKline - Business & Products
About:
Big Pharma,
GSK
About
- GlaxoWellcome = Merger of Burroughs Wellcome & Co. and Glaxo Laboratories in 1995.
- SmithKline Beecham = Merger of Beecham and SmithKline in 1989.
- Sales: £24.3 billion in 2008; £22.7 billion in 2007; £23.2 billion in 2006; £21.7 billion in 2005.
- Profit: £7.8 billion in 2008, 2007, 2006; £6.7 billion in 2005.
- Free Cash Flow: £4785 million in 2008; £3857 million in 2007; £4.7 billion in 2005.
- GSK Biologicals S.A. distributed 1.1 billion doses of vaccines to 169 countries, 3 million doses a day, in 2007; and more than 1.2 billion doses of vaccines to 165 countries, more than 3 million doses per day, with £1.1 billion investment in 2005.
- Corporate member of the Council on Foreign Relations.